The Priority Review

Tag

PT Bio Farma

1 story

  1. Clinical trials

    PT Bio Farma registers Phase 3 trial of in-house recombinant Hepatitis B vaccine at birth dose

    This study was first posted on ClinicalTrials.gov on October 2, 2026. The trial plans to enroll 270 participants and has a planned start date of October 2026 with a planned primary completion date of February 2027.